ArticleBiomedical engineering and computational biology2026
Blind Identification of Altered Functional Subnetworks in Alzheimer's Disease Using Resting-State fMRI.
Article in Biomedical engineering and computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Resting-state functional magnetic resonance imaging (rs-fMRI) is widely used to examine functional connectivity (FC) alterations in neurological disorders such as Alzheimer's disease (AD). Traditional studies either employ whole-brain analyses or focus on specific regions, yet the vast number of FCs and their interrelations complicate interpretation. This study adopts a data-driven, hypothesis-free approach to detect altered functional subnetworks in AD. Methods: Independent component analysis (ICA) was applied to FC matrices from 34 AD patients and 49 healthy controls (HCs) from the Alzheimer's Disease Neuroimaging Initiative (ADNI). After pruning, significant subnetworks distinguishing AD from HC were identified. Graph theoretical parameters were computed for each subnetwork, and their associations with Mini-Mental State Examination (MMSE) scores were assessed. Results: Three subnetworks effectively differentiated AD patients from HCs. One subnetwork showed significant group differences in network strength, clustering coefficient, and local efficiency, despite no whole-brain differences. Abnormal functional lateralization also emerged within subnetworks. Moreover, FC weights in the identified subnetworks positively correlated with MMSE scores, linking cognitive performance to subnetwork connectivity. Conclusion: These results demonstrate the utility of a data-driven approach in detecting AD-specific altered subnetworks. By providing a modular perspective, this method facilitates targeted examination of connectivity changes, improves interpretability, and deepens understanding of functional disruptions in AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.